Atlas Trials

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Clinical trial NCT07424287 · RECRUITING

Trial details

NCT number
NCT07424287
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
NMIBC
Start date
2026-07-13
Primary completion
2030-06-01
Enrollment
236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.